Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype

Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is associated with development of acute hemolytic anemia (AHA) induced by a number of drugs. We provide guidance as to which G6PD genotypes are associated with G6PD deficiency in males and females. Rasburicase is contraindicated in G6PD‐deficient p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Relling, M V, McDonagh, E M, Chang, T, Caudle, K E, McLeod, H L, Haidar, C E, Klein, T, Luzzatto, L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2014
Gaiak:
CPIC Guidelines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111801/
https://ncbi.nlm.nih.gov/pubmed/24787449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.97
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak